AnalystsKeith TapperKeith Tapper's Stock Forecasts
AnalystsKeith Tapper
Sectors:
Industries:
Analyst Ranking
Top 41%
#2209 out of 5342 analysts
Average Return
+11.61%
Win Rate
57%4 out of 7
Risk vs Reward
Poor
Good
Keith Tapper's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neurogene IncNGNE | +87.14% | $10.89 | $20.38 | 2025-04-14 - 2026-04-10 | Buy |
Neurogene IncNGNE | +36.92% | $15.33 | $20.99 | 2024-11-20 - 2025-11-19 | Buy |
Acadia Pharmaceuticals IncACAD | +35.68% | $16.37 | $22.21 | 2024-06-27 - 2025-06-26 | Buy |
Taysha Gene Therapies IncTSHA | +11.32% | $2.17 | $2.41 | 2024-06-27 - 2025-06-26 | Buy |
Keith Tapper Analyst Color
Get additional color on Keith Tapper's coverage of popular stocks
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.